New study aims to make breast cancer treatment safer and more tolerable
Symptom relief
Not yet recruiting
This study tests if giving extra medications before treatment can prevent common side effects like diarrhea and rash from the drug capivasertib when used with fulvestrant for advanced HR+/HER2- breast cancer. About 108 adults with this type of breast cancer will take part. The go…
Phase: PHASE2 • Sponsor: Maryam Lustberg • Aim: Symptom relief
Last updated May 11, 2026 06:27 UTC